Darbeopoetin

DRUG2 trials

Sponsors

Royal Alexandra Hospital, Yale University

Conditions

MDS (Myelodysplastic Syndrome)Traumatic Brain Injury

Phase 2

Safety of Darbepoetin Alfa Treatment in Patients With Severe Traumatic Brain Injury

CompletedNCT00375869

Royal Alexandra HospitalTraumatic Brain Injury

Start: 2006-11-30End: 2009-12-31Updated: 2012-03-05

Luspatercept + Darbepoetin in MDS

RecruitingNCT07096297

Yale UniversityMDS (Myelodysplastic Syndrome)

Start: 2025-12-16End: 2030-08-01Target: 60Updated: 2026-09-14